XERIS PHARMACEUTICALS INC Retained Earnings
XERIS PHARMACEUTICALS INC had Retained Earnings of -$383.31 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-08-05
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$383.31M.
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$355.80M.
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$337.38M.
- 2020-09-30: Retained Earnings (Accumulated Deficit) -$315.53M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2021-06-30 | -$383.31M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$355.80M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$337.38M 10-Q · filed 2021-08-05 | |
| 2020-09-30 | -$315.53M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$299.53M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$275.43M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$246.25M 10-K · filed 2021-03-09 | |
| 2019-09-30 | -$213.16M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$180.33M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | -$145.94M 10-Q · filed 2019-08-06 | |
| 2018-12-31 | -$120.67M 10-K · filed 2021-03-09 | |
| 2018-09-30 | -$100.25M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$85.48M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | -$72.49M 10-Q · filed 2019-08-06 | -$72.49M 10-Q · filed 2019-05-09 |
| 2017-12-31 | -$60.59M 10-K · filed 2020-03-12 | |
| 2016-12-31 | -$34.03M 10-K · filed 2019-03-06 |